Insulin‐Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach

Arthritis & Rheumatology

Fecha de publicación: 16 December 2019

DOI: https://doi.org/10.1002/art.41190

Autores: Lorna Gallagher, Sian Cregan, Monika Biniecka, Clare Cunningham, Douglas J. Veale, David J. Kane, Ursula Fearon, Ronan H. Mullan.

Background: To investigate a role for insulin‐resistant pathways in inflammation and therapeutic targeting for disease modification in rheumatoid arthritis (RA ).